Spontaneous pneumothorax (SP) secondary to the acquired immunodeficiency syndrome (AIDS) emerged in the decade of the 1980s. It has become an increasingly difficult condition to treat successfully both for the pulmonary internist and the surgeon. AIDS-related SP is complicated by a virulent form of necrotizing subpleural necrosis that results in diffuse air leaks that are refractory to the standard, traditional forms of therapy which enjoy good success for SP related to classic subpleural bleb disease. AIDS-related SP carries a high mortality rate despite treatment, independent of the development of primary respiratory failure. In reviewing our experience of 46 
Spontaneous pneumothorax (SP) secondary to the acquired immunodeficiency syndrome (AIDS) emerged in the decade of the 1980s. It has become an increasingly difficult condition to treat successfully both for the pulmonary internist and the surgeon. AIDS-related SP is complicated by a virulent form of necrotizing subpleural necrosis that results in diffuse air leaks that are refractory to the standard, traditional forms of therapy which enjoy good success for SP related to classic subpleural bleb disease. AIDS-related SP carries a high mortality rate despite treatment, independent of the development of primary respiratory failure. In reviewing our experience of 46 The AIDS-defining conditions are listed in Table 1 ; interestingly, a polymicrobial opportunistic infection was identified in 29 percent of those who had PCP. There was no correlation between the development of bilateral SP and presence of a polymicrobial opportunistic infection. Of the 46 patients, nine had small pneumothoraces occupying <10 percent of one hemithorax. These nine were treated by observation (three patients), thoracentesis (one patient), or placement of a smallbore catheter (Cook) (five patients). Because their pneumothoraces were small and easily managed, they were excluded from further analysis.
The remaining 36 patients were divided into three groups according to treatment. The standard treatment group included patients treated with chest tubes and tetracycline/doxycycline pleurodesis and includes 35 patients. The VATS group consisted of eight patients treated by VATS-directed talc poudrage. The thoracotomy group consisted of three subjects treated by open thoracotomy. All but one patient in the latter two groups received standard therapy prior to VATS or thoracotomy. Only three patients were treated by thoracotomy, and the small number of patients precludes any meaningful statistical analysis. Thoracotomy was successful in 2 (66 percent) of the patients, but the average postoperative stay was 10 days and the average cost was $4,990.
The one patient who died in the small thoracotomy group of patients (n=3) suffered from bilateral pneumothoraces due to severe PCP, was blind from cytomegalovirus retinitis, and had severe AIDSassociated encephalopathy. The patient in the VATStalc group (n=8) who died suffered from AIDS encephalopathy, polymicrobial enteric infection, severe malnutrition and wasting, and PCP; he had bilateral complete pneumothoraces that could never be completely evacuated despite multiple chest tubes. DISCUSSION Due to the retrospective nature of this review, statistically conclusive data are difficult to extract and strong recommendations cannot be made with authority. Nevertheless, meaningful clinical insights from this report update our previous study from November 1992 and represent the largest single-institution experience with AIDS-related SP reported in the English literature (to our knowledge). Our results show that the success rate for standard therapy is poor (26 percent) for moderate-to-large, expanding, unstable AIDS-related SP; small stable pneumothoraces did well with minimal treatment. The major factor causing failure of standard SP therapy was the large and persistent air leak into the pleural space. Even multiple chest tubes often failed to completely evacuate the pleural space and, in patients whose pleural space could be fully evacuated, air usually easily reaccumulated when the chest tubes were clamped after instillation of tetracycline or doxycycline. Unless close contact between the visceral and parietal pleura is achieved, pleurodesis rarely succeeds.
In contrast to standard treatment, the VATS-talc procedure applies immediate chest tube suction at the completion of the procedure which allows immediate pleural apposition after talc application. Although most VATS-treated patients had a continuous air leak, the leaks uniformly resolved over a 24-to 48-h period. Talc induces a granulomatous pleuritis that is a more vigorous form of inflammation than the fibrinous pleuritis caused by tetracycline or doxycycline. In addition, it is less invasive and does not have the morbidity, blood loss, or risk of blood exposure associated with thoracotomy. As our results show, VATS treatment is usually successful and is associated with shorter and cheaper hospital stays.
The risks involved with VATS and talc poudrage are difficult to separate from the underlying lung disease being treated. Pleuritic pain, often severe, usually occurred and required parenteral narcotics for 24 to 48 h following surgery; following this, pain was easily managed with oral nonnarcotic agents and no patient was discharged from the hospital following VATS-poudrage on a regimen of outpatient narcotic therapy. The occurrence of fever (up to 38°C) was universally seen in all patients and indicated a satisfactory inflammatory pleuritis. Often there was some component of hypostatic atelectasis due to pain. No patient developed talc aspiration pneumonitis or adult respiratory distress syndrome from this procedure. In an effort to shorten the hospital stay and improve the outcome of AIDS-related SP, we offer the following "stepped-care" tiered approach as a reasonable treatment strategy.
(1) Patients with AIDS-related SP should be treated with pleural drainage appropriate to the degree of pneumothorax on the hospital admission chest radiograph. Small, stable, asymptomatic pneumothoraces often do well if treated with a single thoracentesis or small-bore (Cook) catheter.
(2) Persistent air leak and incomplete expansion despite the presence of a small-bore polyurethane intercostal catheter should be treated with a largebore plastic chest tube immediately; delays in advancing to a more aggressive pleural drainage procedure will only lengthen the hospital stay and may lead to further patient deconditioning from prolonged bed rest. Further drainage attempts utilizing additional small-bore polyurethane intercostal catheters were uniformly unsuccessful in this series.
(3) As many tubes as are necessary to achieve complete expansion of the affected lung should be utilized; patients who fail to achieve complete expansion, or those with a persistent, large-volume air leak, are not candidates for chemical pleurodesis and should be treated with VATS-talc poudrage.
(4) Due to the favorable results with VATS-talc poudrage, thoracotomy and pleurectomy rarely should be used.
(5) Using VATS-talc poudrage as initial therapy should be considered in AIDS patients with large SPs that do not immediately resolve with aggressive pleural drainage.
ADDENDUM
Since the submission of this article, four consecutive additional patients were subsequently admitted to the hospital with large, symptomatic AIDS-related SP. These four patients were successfully treated with VATS-talc poudrage as initial therapy (following emergency department placement of large-bore pleural chest tubes). After adding these patients to the present cohort of study patients, Table 3 illustrates our entire experience.
